Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study

TY - JOUR

T1 - Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia

T2 - a prospective cohort study

AU - Yang, Yuan

AU - Tang, Zengwei

AU - Huang, Yuzhou

AU - Hu, Qinglin

AU - Wang, Shuqing

AU - Ji, Jiang

AU - Du, Yali

AU - Yang, Chen

AU - Chen, Miao

AU - Hu, Shimin

AU - Han, Bing

N1 - Funding Information: We would like to thank all the patients who participated in this study and their supportive families, as well as the investigators and clinical research staff from our centers. This prospective study was supported by findings from CAMS Innovation Fund for Medical Sciences (CIFMS 2021-I2M-1-003), National High Level Hospital Clinical Research Funding (2022-PUMCH-C-026, 2022-PUMCH-D-002, 2022-PUMCH-B-046), Peking Union Medical College Hospital Youth Research Foundation (PUMCH201912367) and Beijing Natural Science Foundation (2023):(7232109). The funders played no roles in the study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the article for publication. All authors have no financial or non-financial conflicts to disclosure in this study.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85159013727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159013727&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00845-3

DO - 10.1038/s41408-023-00845-3

M3 - Letter

C2 - 37160872

AN - SCOPUS:85159013727

SN - 2044-5385

VL - 13

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 74

ER -